Shareholders meeting 2016

Pierre Gurdjian is a senior professional in the field of Philanthropy and Education. He is Philanthropy Partner of the RVVZ Foundation since the beginning of 2015, and President of the Board of Directors of the Université Libre de Bruxelles, effective January 2016 .

Before he was a Senior Partner at McKinsey and Co. where he was active for nearly three decades. He led the Belgian office between 2005 and 2012. His professional focus centered on supporting organizations through major change and developing human capital, particularly the leadership of their top teams. He pursued a strong interest in drawing lessons of leadership from philosophy and wisdom.

He teaches a graduate course in CEO Leadership at the Solvay Business School of the Université Libre de Bruxelles.

Ulf Wiinberg is a pharmaceutical industry professional. Ulf started as a sales representative at Lederle Laboratories in Sweden, which later was acquired by Wyeth. At Wyeth, Ulf was President of the global consumer health care business, and later President for the European pharma business and strategically responsible for biotechnology and vaccines. Ulf served as a member of the management committee from 2002-2008. From 2008 to end of 2014, Ulf was the CEO of Lundbeck, a Danish company focusing on brain diseases.

During his career, Ulf has worked on development and in production of pharmaceutical products and vaccines that can make a big difference for patients. Ulf has also served on the boards of the industry associations for the pharmaceutical and consumer healthcare business, Pharma, Efpia and WSMI.

Ulf is today a non-executive Board member at Alfa Laval, a Swedish industrial company, and Nestle Health and Science, a consumer healthcare company. He is also the Chairman of Avillion, a company that helps large pharmaceutical companies finance and operate late stage development programs.